
Is CRL (Charles River Laboratories International, Inc.) Halal or Haram?
While Charles River Laboratories' core business in medical research and diagnostics is permissible, the stock currently fails AAOIFI financial screens due to excessive leverage. Specifically, its debt-to-market cap ratio stands at 37.8%, exceeding the strict 33% threshold, making the stock Doubtful for Muslim investors despite acceptable interest income (0.12%) and cash levels (2.6%).
Price Chart (5D)
CRL — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-06-08 | 182.80 | 184.00 | 182.80 | 183.70 | 10K | +0.49% |
| 2026-06-05 | 187.18 | 187.35 | 180.55 | 181.34 | 519K | -3.12% |
| 2026-06-04 | 182.00 | 187.95 | 180.60 | 185.79 | 737K | +2.08% |
| 2026-06-03 | 172.75 | 181.05 | 169.46 | 179.87 | 536K | +4.12% |
| 2026-06-02 | 179.00 | 181.76 | 172.17 | 174.79 | 752K | -2.35% |
| 2026-06-01 | 180.28 | 184.68 | 178.06 | 182.07 | 996K | +0.99% |
| 2026-05-29 | 181.34 | 184.83 | 177.01 | 180.71 | 1.0M | -0.35% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for CRL
Business Activity
Permissible
Charles River Laboratories passes the business activity screen as its core operations in drug discovery, safety testing, and providing rodent research models are permissible under Islamic finance principles.
Debt / Market Cap
37.83%
Interest Income
0.12%
Cash & Securities
2.64%
About Charles River Laboratories International, Inc. (CRL)
Charles River Laboratories International, Inc. operates as a leading non-clinical contract research organization supporting drug discovery and safety testing worldwide. The company provides critical services for pharmaceutical development, including the production of specialized rodent research models used extensively by medical researchers.
For Muslim investors using AAOIFI standards, CRL is currently classified as Doubtful. While the underlying medical research business is perfectly halal, the stock fails the financial screening criteria due to high leverage, meaning it does not currently align with strict Islamic investment guidelines.
The primary concern from an Islamic finance perspective is the company's debt-to-market capitalization ratio, which sits at 37.8%, breaching the 33% maximum limit. On a positive note, its interest-bearing cash and securities represent only 2.6% of its market cap, and interest income is negligible at 0.12% of total revenue.
Halal investors should monitor CRL's balance sheet in upcoming quarters. If the company actively reduces its debt burden or if its market capitalization increases sufficiently to bring the debt ratio below the 33% threshold, the stock could become fully compliant.
CEO
James C. Foster
Employees
18,700
IPO Date
2000-06-23
Headquarters
Wilmington, MA, US
Website
www.criver.comCRL Key Financial Statistics
Revenue
$4.02B
Net Income
$-144.3M
EPS (Diluted)
$-2.91
Stock Price
164.25
Beta
1.62
52-Week Range
113.89-228.88
Total Debt
$3.07B
Total Equity
$3.16B
Current Ratio
1.29
CRL Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
-0.9%
Prior year: $4.05B
Net Debt
$2.85B
Cash: $213.8M — Debt: $3.07B
Frequently Asked Questions About CRL
Is CRL (Charles River Laboratories International, Inc.) stock halal to invest in?▾
What does Charles River Laboratories International, Inc. do?▾
What screening criteria were used for CRL?▾
When was CRL last screened?▾
Disclaimer
This shariah compliance assessment for CRL (Charles River Laboratories International, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.